284 studies found for:    TRA
Show Display Options
Rank Status Study
21 Completed Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo
Condition: MILD TO SEVERE ACNE VULGARIS
Interventions: Drug: CLIND PHOSPHATE (1.2%) AND TRETINOIN (0.025%) TOPICAL GEL;   Drug: ZIANA®;   Drug: Vehicle Control
22 Completed Clinical Evaluation of the Photoallergy Potential of Atralin Gel
Condition: Healthy
Intervention: Drug: Atralin (tretinoin) gel, 0.05%
23 Suspended Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of Melasma
Condition: Melasma
Interventions: Drug: arbutin, tretinoin, triamcinolone;   Drug: Triluma
24 Completed Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer
Conditions: Carcinoma, Basal Cell;   Carcinoma, Squamous Cell;   Skin Neoplasms
Interventions: Drug: Tretinoin 0.1% cream or placebo;   Other: Placebo
25 Completed Split-face Tolerability Comparison Between Adapalene-BPO Gel Versus Tretinoin Gel
Condition: Acne Vulgaris
Interventions: Drug: Epiduo Gel;   Drug: Retin-A Micro Microsphere 0.1%
26 Completed
Has Results
Phase II 5-Azacytidine Plus VPA Plus ATRA
Conditions: Myelodysplastic Syndrome;   Acute Myelogenous Leukemia
Interventions: Drug: 5-Azacytidine (5-aza);   Drug: Valproic Acid;   Drug: All-Trans Retinoic Acid (ATRA)
27 Withdrawn Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin Cream
Condition: Medication Reaction
Intervention: Drug: Tretinoin
28 Completed Single Dose of 9-cis-retinoic Acid in Hepatic Patients
Condition: Hepatic Insufficiency
Intervention: Drug: 9-cis-retinoic acid
29 Completed Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Pioglitazone and Tretinoin;   Drug: Tretinoin and Pioglitazone HCL;   Drug: Placebo
30 Completed Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch Marks
Conditions: Stretch Marks;   Striae;   Treatment
Interventions: Drug: Tretinoin cream 0.005%;   Device: Superficial Dermabrasion
31 Unknown  Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin
Condition: Acne
Interventions: Drug: tretinoin microsphere 0.04% gel;   Drug: vehicle gel
32 Completed Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo
Condition: Acne
Interventions: Drug: Tretinoin;   Drug: placebo
33 Completed Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%
Condition: Healthy
Intervention: Drug: Atralin (tretinoin) Gel, 0.05%
34 Completed
Has Results
Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage
Condition: Photoaging
Interventions: Drug: adapalene gel, 0.3%;   Drug: tretinoin 0.05% emollient cream
35 Completed 13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer
Conditions: Drug Toxicity;   Lung Cancer
Interventions: Drug: 13-cis retinoic acid;   Dietary Supplement: Tocopherol
36 Completed Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia
Condition: Leukemia
Interventions: Drug: arsenic trioxide;   Drug: idarubicin;   Drug: tretinoin
37 Recruiting All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
Conditions: Purpura;   Idiopathic Thrombocytopenic Purpura
Interventions: Drug: All-Trans Retinoid Acid(ATRA);   Drug: Dexamethasone
38 Active, not recruiting Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors
Condition: Brain Tumors
Intervention: Drug: temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid
39 Completed
Has Results
Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea
Condition: Rosacea
Interventions: Drug: Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel;   Drug: Placebo gel
40 Recruiting Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: ATRA+arsenic;   Drug: ATRA+chemo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years